The eradication rates for non-bismuth quadruple therapy and standard triple therapy for 7 or 10 days were 91.4 % ( 74/81 ) , 79.3 % ( 65/82 ) and 79.5 % ( 66/83 ) as determined by intention-to-treat analysis ( ITT ) .